- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 217
PsiQuantum crosses off $450m in funding
M12 returned to reinvest in the quantum computer developer at a valuation topping $3bn, boosting its overall funding to $665m.
Jul 28, 2021iCapital Network manages to raise $440m
Ping An Global Voyager Fund has returned to back the asset management platform developer’s latest round, at a $4bn valuation.
Jul 28, 2021Microvast ties up $3bn reverse takeover
Koch Industries and Oshkosh are backing a $540m private placement supporting the merger between advanced battery maker Microvast and a special purpose acquisition company.
Jul 28, 2021Fireblocks traps $310m in series D round
The digital asset technology provider boosted its valuation to over $2bn in a round co-led by Siam Commercial Bank’s SCB 10X vehicle.
Jul 28, 2021Landis houses $165m in series A funding
Roc Nation's Arrive unit participated in a debt and equity round that boosted the home rental-to-mortgage service provider's total financing to $182m.
Jul 28, 2021NGIF closes debut fund
Canadian Gas Association's NGIF Cleantech Ventures has secured almost $40m for the second close of a fund backed by several corporates.
Jul 28, 2021Herbst leaves Nvidia to set up GFT Ventures
Jeff Herbst has departed from his role heading Nvidia GPU Ventures to join Samsung Ventures alumnus Jay Eum at the recently formed GFT Ventures.
Jul 28, 2021Nobell tastes $75m in series B round
AgFunder was anong the investors that helped the plant-derived cheese product developer formerly known as Alpine Roads take its total funding past $100m.
Jul 28, 2021Audax acquires majority stake in Flashpoint
Audax Private Equity has become the Bloomberg and Cisco-backed threat intelligence software provider’s majority shareholder.
Jul 28, 2021RxCelerate explores corporate venturing
The newly formed RxCapital has made its first investment, in metabolic and cardiovascular disease drug developer Rivus Pharmaceuticals' $35m series A round.
Jul 28, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


